What's new

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised

May 15, 2025 - 15:22
 0
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

CMS and ASTP make broad health tech info request 

Next Article

Human medicines European public assessment report (EPAR): Filsuvez, birch bark e...

Related Posts

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - July 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 July 2025, 11:00 (CEST) to 22 July 2025, 12:00 (CEST)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0